Neoadjuvant Compound 121564 Plus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer
NCT03480230
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Non-Small Cell Lung Cancer Stage
Interventions
DRUG:
Compound 121564
Sponsor
Arafat Tfayli
Collaborators
[object Object]
[object Object]